Patents by Inventor Marco GERLINGER

Marco GERLINGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCER USING A CEA CD3 BISPECIFIC ANTIBODY AND A TGFbeta SIGNALING INHIBITOR
    Publication number: 20230277661
    Abstract: The present invention relates to the treatment of cancer, in particular to the treatment of cancer using a CEA CD3 bispecific antibody and a TGF? signaling inhibitor.
    Type: Application
    Filed: April 28, 2023
    Publication date: September 7, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Marco GERLINGER, Maria SEMIANNIKOVA
  • TREATMENT OF CANCER USING A CEA CD3 BISPECIFIC ANTIBODY AND A WNT SIGNALING INHIBITOR
    Publication number: 20220017623
    Abstract: The present invention relates to the treatment of cancer, in particular to the treatment of cancer using a CEA CD3 bispecific antibody and a Wnt signaling inhibitor.
    Type: Application
    Filed: October 11, 2021
    Publication date: January 20, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Marco GERLINGER, Reyes GONZALEZ-EXPOSITO, Maria SEMIANNIKOVA